Generic and Biosimilar Medicine Conference

The Generic and Biosimilar Medicine Conference, occurring at the Bethesda North Marriott Hotel & Conference Center in Rockville, United States, is an annual event dedicated to the critical discourse around the generics and biosimilars sector. This conference, set for November 2-4, 2026, serves as a pivotal platform for regulatory, scientific, and policy discussions that shape the industry landscape. Attendees will have the opportunity to explore significant advancements in generics and biosimilars, gaining insights directly from U.S. regulatory experts. The event aims to provide a comprehensive understanding of how current policies and regulations influence market dynamics and patient access to affordable medicines. Professionals from various backgrounds, including bench scientists, technical experts, policy makers, and industry leaders, will gather to discuss the latest innovations, emerging technologies, and best practices in the generics and biosimilars field. The conference features numerous networking opportunities, allowing attendees to connect with global influencers and enhance their professional development. Participants will benefit from expert-led sessions that cover important topics such as the implementation of recent regulations, FDA expectations, and the implications of legislation on patient access. Additionally, exhibitors will have the chance to showcase their companies, engage with industry decision-makers, and promote their brands through a range of advertising opportunities linked to the event. With customizable digital assets and social media content available, sponsors can effectively increase their visibility leading up to and during the conference.